BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang LY, Zhang YQ, Zeng YZ, Zhu JL, Chen H, Wei XL, Liu LJ. TRPC1 inhibits the proliferation and migration of estrogen receptor-positive Breast cancer and gives a better prognosis by inhibiting the PI3K/AKT pathway. Breast Cancer Res Treat 2020;182:21-33. [PMID: 32415497 DOI: 10.1007/s10549-020-05673-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Schnipper J, Kouba S, Hague F, Girault A, Telliez MS, Guénin S, Ahidouch A, Pedersen SF, Ouadid-Ahidouch H. Acid Adaptation Promotes TRPC1 Plasma Membrane Localization Leading to Pancreatic Ductal Adenocarcinoma Cell Proliferation and Migration through Ca2+ Entry and Interaction with PI3K/CaM. Cancers (Basel) 2022;14:4946. [PMID: 36230869 DOI: 10.3390/cancers14194946] [Reference Citation Analysis]
2 Sun Y, Zboril EK, De La Chapa JJ, Chai X, Da Conceicao VN, Valdez MC, Mchardy SF, Gonzales CB, Singh BB. Inhibition of Ca2+ entry by capsazepine analog CIDD-99 prevents oral squamous carcinoma cell proliferation. Front Physiol 2022;13:969000. [DOI: 10.3389/fphys.2022.969000] [Reference Citation Analysis]
3 Chen W, Zhang Y, Li R, Huang W, Wei X, Zeng D, Liang Y, Zeng Y, Chen M, Zhang L, Gao W, Zhu Y, Li Y, Zhang G. Notch3 Transactivates Glycogen Synthase Kinase-3-Beta and Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer Cells. Cells 2022;11:2872. [DOI: 10.3390/cells11182872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bera K, Kiepas A, Zhang Y, Sun SX, Konstantopoulos K. The interplay between physical cues and mechanosensitive ion channels in cancer metastasis. Front Cell Dev Biol 2022;10:954099. [DOI: 10.3389/fcell.2022.954099] [Reference Citation Analysis]
5 Schnipper J, Kouba S, Hague F, Girault A, Rybarczyk P, Telliez M, Guénin S, Tebbakha R, Sevestre H, Ahidouch A, Pedersen SF, Ouadid-ahidouch H. The TRPC1 Channel Forms a PI3K/CaM Complex and Regulates Pancreatic Ductal Adenocarcinoma Cell Proliferation in a Ca2+-Independent Manner. IJMS 2022;23:7923. [DOI: 10.3390/ijms23147923] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Shi G, Cui W, Liu Y, Li L, Sun Y, Zhang X, Jiao J. TRPC1 correlates with poor tumor features, radiotherapy efficacy and survival in tongue squamous cell carcinoma. Biomark Med 2022. [PMID: 35833829 DOI: 10.2217/bmm-2021-0208] [Reference Citation Analysis]
7 Wang Y, Zhang C. Aberrant TRPC1 expression reflects stromal cervical invasion, lymphovascular invasion, elevated FIGO stage, and poor survival in resectable endometrial carcinoma patients. J Clin Lab Anal 2022;:e24560. [PMID: 35754147 DOI: 10.1002/jcla.24560] [Reference Citation Analysis]
8 Fallah HP, Ahuja E, Lin H, Qi J, He Q, Gao S, An H, Zhang J, Xie Y, Liang D. A Review on the Role of TRP Channels and Their Potential as Drug Targets_An Insight Into the TRP Channel Drug Discovery Methodologies. Front Pharmacol 2022;13:914499. [DOI: 10.3389/fphar.2022.914499] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Chen L, Shan G, Ge M, Qian H, Xia Y. Transient Receptor Potential Channel 1 Potentially Serves as a Biomarker Indicating T/TNM Stages and Predicting Long-Term Prognosis in Patients With Renal Cell Carcinoma. Front Surg 2022;9:853310. [PMID: 35548183 DOI: 10.3389/fsurg.2022.853310] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ke C, Long S. Dysregulated transient receptor potential channel 1 expression and its correlation with clinical features and survival profile in surgical non-small-cell lung cancer patients. J Clin Lab Anal 2022;:e24229. [PMID: 35106847 DOI: 10.1002/jcla.24229] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Tai YK, Chan KKW, Fong CHH, Ramanan S, Yap JLY, Yin JN, Yip YS, Tan WR, Koh APF, Tan NS, Chan CW, Huang RYJ, Li JZ, Fröhlich J, Franco-obregón A. Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach. Front Oncol 2022;11:783803. [DOI: 10.3389/fonc.2021.783803] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Canales Coutiño B, Mayor R. Reprint of: Mechanosensitive ion channels in cell migration. Cells Dev 2021;:203730. [PMID: 34456177 DOI: 10.1016/j.cdev.2021.203730] [Reference Citation Analysis]
13 Bektur Aykanat NE, Şahin E, Kaçar S, Bağcı R, Karakaya Ş, Burukoğlu Dönmez D, Şahintürk V. Investigation of the effect of hyperthyroidism on endoplasmic reticulum stress and tran- sient receptor potential canonical 1 channel in the kidney. Turk J Med Sci 2021;51:1554-63. [PMID: 33754657 DOI: 10.3906/sag-2007-109] [Reference Citation Analysis]
14 Zhang YQ, Zhang F, Zeng YZ, Chen M, Huang WH, Wu JD, Chen WL, Gao WL, Bai JW, Yang RQ, Zeng HC, Wei XL, Zhang GJ. Mutant p53 and Twist1 Co-Expression Predicts Poor Prognosis and Is an Independent Prognostic Factor in Breast Cancer. Front Oncol 2021;11:628814. [PMID: 34249678 DOI: 10.3389/fonc.2021.628814] [Reference Citation Analysis]
15 Cui C, Zhang Y, Liu G, Zhang S, Zhang J, Wang X. Advances in the study of cancer metastasis and calcium signaling as potential therapeutic targets. Exploration of Targeted Anti-tumor Therapy. [DOI: 10.37349/etat.2021.00046] [Reference Citation Analysis]
16 Tai YK, Wing Chan KK, Hua Fong CH, Ramanan S, Yee Yap JL, Yin JN, Yip YS, Tan WR, Fern Koh AP, Tan NS, Chan CW, Ju Huang RY, Franco-obregón A. Modulated TRPC1 expression predicts sensitivity of breast cancer to doxorubicin and magnetic field therapy: segue towards a precision medicine approach.. [DOI: 10.1101/2021.04.30.442085] [Reference Citation Analysis]
17 Canales Coutiño B, Mayor R. Mechanosensitive ion channels in cell migration. Cells Dev 2021;166:203683. [PMID: 33994356 DOI: 10.1016/j.cdev.2021.203683] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
18 Zeng YZ, Zhang YQ, Chen JY, Zhang LY, Gao WL, Lin XQ, Huang SM, Zhang F, Wei XL. TRPC1 Inhibits Cell Proliferation/Invasion and Is Predictive of a Better Prognosis of Esophageal Squamous Cell Carcinoma. Front Oncol 2021;11:627713. [PMID: 33854967 DOI: 10.3389/fonc.2021.627713] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]